FDA proposes rule to expose hidden foreign drug factories and boost domestic production
The FDA announced a sweeping rule proposal requiring drug manufacturers to disclose foreign production facilities and incentivizing domestic manufacturing. This aims to increase transparency in the drug supply chain and reduce U.S. reliance on imported drugs. The move could enhance drug safety and national security by uncovering hidden factories.